Literature DB >> 19937391

Rodent rhabdomyosarcoma: comparison between total choline concentration at H-MRS and [18F]-fluoromethylcholine uptake at PET using accurate methods for collecting data.

Denis Rommel1, Anne Bol, Jorge Abarca-Quinones, Frank Peeters, Annie Robert, Daniel Labar, Christine Galant, Vincent Gregoire, Thierry Duprez.   

Abstract

PURPOSE: To compare choline concentration/amount at proton magnetic resonance spectroscopy (H-MRS) and [18F]-fluoromethylcholine (FCH) uptake at positron emission tomography (PET) in a tumour animal model. PROCEDURES: Twenty-two rats bearing grafted syngenic rhabdomyosarcoma in both thighs were examined on a 3T MR system and on a small animal PET system. Total choline concentration was measured on proton MR spectra using a so-called 'best internal fitting' volume of interest. Choline uptake was expressed as mean and maximum standardized uptake value (SUV and SUVmax, respectively) and as the percent of injected dose (%ID) after tumour delineation on fused PET-MR images. Data sets were displayed on standard scatter plots.
RESULTS: Thirty-six tumours were available for analysis. The area under the curve of the 3.2 ppm choline peak ranged from 69 to 476 (mean, 192) in arbitrary units. Mean SUV values ranged from 0.05 to 0.49 (mean, 0.19) and the %ID from 0.05 to 2.28 (mean, 0.54). Scatter plots failed to reveal quantitative relationship between choline concentration and uptake. Empirically data-driven cut-off lines applied to choline amount (choline concentration x tumour volume) versus choline uptake suggested a paradoxically negative relationship.
CONCLUSION: Total choline concentration did not correlate with FCH uptake in a tumour experimental model. A negative feedback of high values of total choline amount on cellular FCH uptake seemed to be present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937391     DOI: 10.1007/s11307-009-0283-3

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  33 in total

Review 1.  Choline transport for phospholipid synthesis.

Authors:  Vera Michel; Zongfei Yuan; Shobha Ramsubir; Marica Bakovic
Journal:  Exp Biol Med (Maywood)       Date:  2006-05

2.  Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method.

Authors:  R Katz-Brull; H Degani
Journal:  Anticancer Res       Date:  1996 May-Jun       Impact factor: 2.480

3.  PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.

Authors:  Jean-Noël Talbot; Fabrice Gutman; Laetitia Fartoux; Jean-Didier Grange; Nathalie Ganne; Khaldoun Kerrou; Dany Grahek; Françoise Montravers; Raoul Poupon; Olivier Rosmorduc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-27       Impact factor: 9.236

Review 4.  In vivo magnetic resonance spectroscopy in cancer.

Authors:  Robert J Gillies; David L Morse
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

5.  Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

Authors:  T R DeGrado; R E Coleman; S Wang; S W Baldwin; M D Orr; C N Robertson; T J Polascik; D T Price
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

6.  Choline transporter as a novel target for molecular imaging of cancer.

Authors:  Toshihiko Hara; Aditya Bansal; Timothy R DeGrado
Journal:  Mol Imaging       Date:  2006 Oct-Dec       Impact factor: 4.488

7.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Authors:  Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal:  Radiology       Date:  2004-11       Impact factor: 11.105

8.  [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine.

Authors:  Ren Iwata; Claudio Pascali; Anna Bogni; Shozo Furumoto; Kazunori Terasaki; Kazuhiko Yanai
Journal:  Appl Radiat Isot       Date:  2002-09       Impact factor: 1.513

9.  Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.

Authors:  Mei Tian; Hong Zhang; Noboru Oriuchi; Tetsuya Higuchi; Keigo Endo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

10.  18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.

Authors:  Matthias T Wyss; Bruno Weber; Michael Honer; Nicolas Späth; Simon M Ametamey; Gerrit Westera; Beata Bode; Achim H Kaim; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-20       Impact factor: 9.236

View more
  1 in total

1.  Transport and metabolism of radiolabeled choline in hepatocellular carcinoma.

Authors:  Yu Kuang; Nicolas Salem; David J Corn; Bernadette Erokwu; Haibin Tian; Fangjing Wang; Zhenghong Lee
Journal:  Mol Pharm       Date:  2010-09-21       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.